Science Explorer Back to mapMap

Most cited papers from Ambry Genetics (United States)

What are the most cited papers from Ambry Genetics (United States)?

The most cited paper from Ambry Genetics (United States) is "Association of Gestational Weight Gain With Maternal and Infant Outcomes" (Rebecca F. Goldstein, Sally K. Abell, Sanjeeva Ranasinha et al., 2017), with 1,699 citations. Next come "Recommendations for interpreting the loss of function PVS1 ACMG/AMP variant criterion" (945) and "Astrocytes from familial and sporadic ALS patients are toxic to motor neurons" (793).

Showing 50 of 60 papers. Every paper with more than 115 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Association of Gestational Weight Gain With Maternal and Infant Outcomes Rebecca F. Goldstein, Sally K. Abell, Sanjeeva Ranasinha et al. · JAMA Open access 6 Jun 2017 1,699
2 Recommendations for interpreting the loss of function PVS1 ACMG/AMP variant criterion Ahmad Abou Tayoun, Tina F. Pesaran, Marina T. DiStefano et al. · Human Mutation Open access 7 Sep 2018 945
3 Astrocytes from familial and sporadic ALS patients are toxic to motor neurons Amanda M. Haidet-Phillips, Mark E. Hester, Carlos J. Miranda et al. · Nature Biotechnology Open access 10 Aug 2011 793
4 Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer Fergus J. Couch, Hermela Shimelis, Chunling Hu et al. · JAMA Oncology Open access 18 Apr 2017 635
5 Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders Markus Wolff et al. · Brain Open access 23 Feb 2017 606
6 Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3/BP4 criteria Vikas Rao Pejaver et al. · The American Journal of Human Genetics Open access 21 Nov 2022 595
7 Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium Laura M. Amendola et al. · The American Journal of Human Genetics Open access 12 May 2016 592
8 Enhanced utility of family-centered diagnostic exome sequencing with inheritance model–based analysis: results from 500 unselected families with undiagnosed genetic conditions Kelly D. Farwell et al. · Genetics in Medicine Open access 30 Oct 2014 479
9 ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG) David T. Miller, Kristy Lee, Noura S. Abul‐Husn et al. · Genetics in Medicine Open access 22 Jun 2023 453
10 Cancer Risks Associated With GermlinePALB2Pathogenic Variants: An International Study of 524 Families Xin Yang et al. · Journal of Clinical Oncology Open access119 authors 16 Dec 2019 440
11 Diagnostic exome sequencing provides a molecular diagnosis for a significant proportion of patients with epilepsy Katherine L. Helbig, Kelly D. Farwell Hagman, Deepali N. Shinde et al. · Genetics in Medicine Open access 21 Jan 2016 370
12 Using the ACMG/AMP framework to capture evidence related to predicted and observed impact on splicing: Recommendations from the ClinGen SVI Splicing Subgroup Logan C. Walker et al. · The American Journal of Human Genetics Open access 22 Jun 2023 354
13 Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients Holly LaDuca, Aaron J. Stuenkel, Jill S. Dolinsky et al. · Genetics in Medicine Open access 24 Apr 2014 339
14 Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing Hermela Shimelis et al. · JNCI Journal of the National Cancer Institute Open access 5 Jun 2018 329
15 De novo variants in neurodevelopmental disorders with epilepsy Henrike Heyne et al. · Nature Genetics Open access 22 Jun 2018 320
16 ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG) David T. Miller, Kristy Lee, Noura S. Abul‐Husn et al. · Genetics in Medicine Open access 17 Jun 2022 295
17 Recommendations for clinical interpretation of variants found in non-coding regions of the genome Jamie M. Ellingford et al. · Genome Medicine Open access 18 Jul 2022 276
18 False-positive results released by direct-to-consumer genetic tests highlight the importance of clinical confirmation testing for appropriate patient care Stephany Tandy-Connor, Jenna Guiltinan, Kate E. Krempely et al. · Genetics in Medicine Open access 22 Mar 2018 274
19 GRIN2B encephalopathy: novel findings on phenotype, variant clustering, functional consequences and treatment aspects Konrad Platzer et al. · Journal of Medical Genetics Open access 4 Apr 2017 261
20 Clinical laboratories collaborate to resolve differences in variant interpretations submitted to ClinVar Steven M. Harrison, Jill S. Dolinsky, Amy E. Knight Johnson et al. · Genetics in Medicine Open access 16 Mar 2017 258
21 Integration Specificity of Phage ϕC31 Integrase in the Human Genome Thomas W. Chalberg, Joylette L. Portlock, Eric C. Olivares et al. · Journal of Molecular Biology 23 Dec 2005 242
22 Genetic and clinical determinants of constitutional mismatch repair deficiency syndrome: Report from the constitutional mismatch repair deficiency consortium Doua Bakry et al. · European Journal of Cancer 15 Jan 2014 237
23 A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patients Holly LaDuca et al. · Genetics in Medicine Open access 12 Aug 2019 234
24 Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis Christopher J. Rhodes et al. · The Lancet Respiratory Medicine Open access118 authors 5 Dec 2018 217
25 De Novo Mutations in Protein Kinase Genes CAMK2A and CAMK2B Cause Intellectual Disability Sébastien Küry et al. · The American Journal of Human Genetics Open access104 authors Nov 2017 204
26 Functional Dysregulation of CDC42 Causes Diverse Developmental Phenotypes Simone Martinelli et al. · The American Journal of Human Genetics Open access 25 Jan 2018 195
27 Sanger Confirmation Is Required to Achieve Optimal Sensitivity and Specificity in Next-Generation Sequencing Panel Testing Wenbo Mu, Hsiao‐Mei Lu, Jefferey Chen et al. · Journal of Molecular Diagnostics Open access 9 Oct 2016 186
28 Association of Breast and Ovarian Cancers With Predisposition Genes Identified by Large-Scale Sequencing Hsiao‐Mei Lu, Shuwei Li, Mary Helen Black et al. · JAMA Oncology Open access 21 Aug 2018 184
29 Germline Genetic Testing After Cancer Diagnosis Allison W. Kurian, Paul H. Abrahamse, Allison Kate Cullen Furgal et al. · JAMA Open access 5 Jun 2023 176
30 The Clinical Genome Resource (ClinGen) Familial Hypercholesterolemia Variant Curation Expert Panel consensus guidelines for LDLR variant classification Joana Rita Chora et al. · Genetics in Medicine Open access 30 Nov 2021 175
31 Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline CDH1 sequence variants Kristy Lee et al. · Human Mutation Open access 11 Oct 2018 175
32 Gene‐specific criteria for PTEN variant curation: Recommendations from the ClinGen PTEN Expert Panel Jessica L. Mester, Rajarshi Ghosh, Tina F. Pesaran et al. · Human Mutation Open access 11 Oct 2018 174
33 YY1 Haploinsufficiency Causes an Intellectual Disability Syndrome Featuring Transcriptional and Chromatin Dysfunction Michele Gabriele et al. · The American Journal of Human Genetics Open access Jun 2017 174
34 The Gene Curation Coalition: A global effort to harmonize gene–disease evidence resources Marina T. DiStefano et al. · Genetics in Medicine Open access 4 May 2022 169
35 Specifications of the ACMG/AMP variant interpretation guidelines for germline TP53 variants Cristina Fortuño et al. · Human Mutation Open access 10 Dec 2020 168
36 Frequency of mutations in a large series of clinically ascertained ovarian cancer cases tested on multi-gene panels compared to reference controls Jenna Lilyquist, Holly LaDuca, Eric C. Polley et al. · Gynecologic Oncology Open access 7 Sep 2017 161
37 Defining the phenotypic spectrum of SLC6A1 mutations Katrine M. Johannesen et al. · Epilepsia Open access 8 Jan 2018 155
38 Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results Mary Pritzlaff, Pia Summerour, Rachel E. McFarland et al. · Breast Cancer Research and Treatment Open access 22 Dec 2016 154
39 Genotype-phenotype correlations in SCN8A -related disorders reveal prognostic and therapeutic implications Katrine M. Johannesen et al. · Brain Open access129 authors 25 Aug 2021 152
40 Association of Gestational Weight Gain With Maternal and Infant Outcomes: A Systematic Review and Meta-analysis Rebecca F. Goldstein, Sally K. Abell, Sanjeeva Ranasinha et al. · Obstetrical & Gynecological Survey Oct 2017 148
41 Diagnostic criteria for constitutional mismatch repair deficiency (CMMRD): recommendations from the international consensus working group Melyssa D. Aronson, Chrystelle Colas, Andrew Y. Shuen et al. · Journal of Medical Genetics 23 Feb 2021 145
42 SYT1-associated neurodevelopmental disorder: a case series Kate Baker et al. · Brain Open access 14 Jul 2018 145
43 HCN1mutation spectrum: from neonatal epileptic encephalopathy to benign generalized epilepsy and beyond Carla Marini et al. · Brain Open access 26 Sep 2018 140
44 Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancer Yanjing Li et al. · Science Translational Medicine Open access 4 Dec 2019 139
45 A Recurrent Missense Variant in AP2M1 Impairs Clathrin-Mediated Endocytosis and Causes Developmental and Epileptic Encephalopathy Ingo Helbig et al. · The American Journal of Human Genetics Open access 16 May 2019 137
46 Type 1 Diabetes Risk in African-Ancestry Participants and Utility of an Ancestry-Specific Genetic Risk Score Suna Önengüt-Gümüşcü et al. · Diabetes Care Open access 18 Jan 2019 137
47 The landscape of reported VUS in multi-gene panel and genomic testing: Time for a change Heidi L. Rehm et al. · Genetics in Medicine Open access 30 Jul 2023 136
48 Closing the gap: Systematic integration of multiplexed functional data resolves variants of uncertain significance in BRCA1, TP53, and PTEN Shawn Fayer, Carolyn Horton, Jennifer N. Dines et al. · The American Journal of Human Genetics Open access 17 Nov 2021 130
49 Clinical features and cancer risk in families with pathogenic CDH1 variants irrespective of clinical criteria Rosa M. Xicola, Shuwei Li, Nicolette Juliana Rodriguez et al. · Journal of Medical Genetics Open access 11 Jul 2019 130
50 Mouse screen reveals multiple new genes underlying mouse and human hearing loss Neil J. Ingham, Selina A. Pearson, Valerie E. Vancollie et al. · PLoS Biology Open access 11 Apr 2019 130

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.